US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

18.58

-0.5300-2.77%

Volume:32.64K

Turnover:606.40K

Market Cap:107.78M

PE:- -

High:18.69

Open:18.62

Low:18.50

Close:19.11

52wk High:21.88

52wk Low:14.38

Shares:5.80M

Float Shares:5.80M

Volume Ratio:0.60

T/O Rate:0.56%

Dividend:0.71

Dividend Rate:3.85%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

CSPC Innovation Pharma, CSPC Pharmaceutical Group Unit, Forecasts H1 Net Profit at 1.18 Billion-1.36 Billion Yuan

CSPC Pharmaceutical - Expects H1 2026 Profit Attributable to Owners of Rmb5.9 Bln–RMB6.2 Bln

THOMSON REUTERS

CSPC Pharmaceutical - Expected Result Due to Significant Increase in Licence Fee Income, Others in Hy

THOMSON REUTERS

CSPC Pharmaceutical Group Stock Falls 2.9% in Hong Kong, Underperforms Competitors

Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$10.31 From HK$12.04, Keeps at Buy

MT Newswires Live

Nomura Adjusts Akeso's Price Target to HK$138.29 From HK$142.50, Keeps at Buy

MT Newswires Live

Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$51.38 From HK$50.54, Keeps at Buy

MT Newswires Live

Chinese biotech overtakes AI as emerging-market growth trade

Srinivasan Sivabalan / Bloomberg

CSPC Pharmaceutical Group (SEHK:1093) Could Be 115% Below Fair Value Following Drug Approval

Simply Wall St.

Obesity Specialty Standardized Weight Management Service System Initiative Launches in China

AKESO (09926) Grants 3,603,500 Share Options and 1,648,500 Restricted Share Units

Akeso Grants 3,603,500 Share Options at HK$ 99.5 Exercise Price Under Employee Incentive Plan

Akeso (SEHK:9926) Partners With MSK, Is The Discount To Fair Value Justified?

Simply Wall St.

Hong Kong Stock Market Analysis: ChangXin IPO Pressure Weighs, Agricultural Inflation Risks Boost Related Stocks

CSPC Pharma's Paliperidone Palmitate Injection Receives Market Approval

CSPC Pharma Wins China Approval for Paliperidone Palmitate Schizophrenia Injection

CSPC Pharmaceutical - Paliperidone Palmitate Injection Receives Marketing Approval

THOMSON REUTERS

Wuxi Biologics Schedules Board Meeting to Review Interim Results

CSPC Pharmaceutical Group Stock Rises 2.2% in Hong Kong, Outperforms Competitors

BeiGene Invests Additional $300 Million in US Expansion, Stock Hits 3-Month High; Hong Kong Stock Connect Innovative Drugs Show Local Strength, 520880 Rises for Third Consecutive Day Against Market

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/KURE/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":18.58,"timestamp":1787598633099,"preClose":19.11,"halted":0,"volume":32643,"delay":0,"changeRate":-0.027734170591313508,"floatShares":5800979,"shares":5800979,"eps":0,"marketStatus":"Trading","change":-0.53,"latestTime":"08-24 15:12:27 EDT","open":18.615,"high":18.69,"low":18.5,"amount":606401.405181,"amplitude":0.009942,"askPrice":18.72,"askSize":100,"bidPrice":18.51,"bidSize":410,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":19.11,"sharesOutstanding":4750002,"nav":18.99,"aum":110160584.96,"dividendRate":0.038471,"bidAskSpread":0.003071,"preHourTrading":{"tag":"盘前","latestPrice":18.5,"preClose":19.11,"latestTime":"07:56 EDT","volume":54,"amount":998.020008,"timestamp":1787572607542,"change":-0.61,"changeRate":-0.03192,"amplitude":0.005128},"postHourTrading":{"tag":"盘后","latestPrice":19.33,"preClose":19.11,"latestTime":"19:13 EDT","volume":111,"amount":2143.44,"timestamp":1787353996933,"change":0.22,"changeRate":0.011512,"amplitude":0.011512},"volumeRatio":0.602988,"impliedVol":0.3186,"impliedVolPercentile":0.6574},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5800979,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.602988,"shares":5800979,"dividePrice":0.7148,"high":18.69,"amplitude":0.009942,"preClose":19.11,"low":18.5,"week52Low":14.3797,"pbRate":"--","week52High":21.875,"institutionHeld":0,"latestPrice":18.58,"committee":0.607843,"eps":0,"divideRate":0.038471,"volume":32643,"delay":0,"ttmEps":0,"open":18.615,"prevYearClose":17.04,"prevWeekClose":19.11,"prevMonthClose":17.28,"prevQuarterClose":15.747,"fiveDayClose":18.6,"twentyDayClose":17.3752,"sixtyDayClose":15.66},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2654016865","title":"CSPC Innovation Pharma, CSPC Pharmaceutical Group Unit, Forecasts H1 Net Profit at 1.18 Billion-1.36 Billion Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=2654016865","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654016865?lang=en_us&edition=fundamental","pubTime":"2026-07-27 17:34","pubTimestamp":1785144884,"startTime":"0","endTime":"0","summary":"CSPC Innovation Pharma, CSPC Pharmaceutical Group unit, forecasts H1 net profit at 1.18 billion-1.36 billion yuanCSPC Innovation Pharmaceutical, a subsidiary of CSPC Pharmaceutical Group, guided for H","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nNDL9WrKMv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089284900.SGD","LU2293690249.USD","BK5011","IE00BZ08YT58.USD","BK1191","LU0963555726.SGD","LU1989772840.SGD","LU0976567544.SGD","01093","LU0545039389.USD","LU1153585028.USD","KURE","LU1051770623.HKD","IE00BJJMRZ35.SGD","LU2293690082.USD","LU2324357040.USD","LU2279689827.SGD","LU0203347892.USD","LU0949170772.SGD","LU0997586515.USD","300765","LU0964806797.USD","LU0211326755.USD","LU0315179316.USD","LU1481599808.USD","03165","LU1923622614.USD","LU1152091754.HKD","LU1078025761.USD","LU0052756011.USD","LU1328277881.USD","LU0920840948.USD","IE0008369823.USD","LU0972486137.USD","LU0390134368.USD","LU2237443978.SGD","LU0140636845.USD","AZN.UK","LU0203345920.USD","IE0008368742.USD","LU1487256676.USD","LU2237443895.HKD","LU0072913022.USD","IE00B4R5TH58.HKD","LU2091194634.USD","LU0122379950.USD","LU0969580561.USD","LU1814569148.SGD","LU1989772923.USD","LU1481600234.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654801502","title":"CSPC Pharmaceutical - Expects H1 2026 Profit Attributable to Owners of Rmb5.9 Bln–RMB6.2 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2654801502","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654801502?lang=en_us&edition=fundamental","pubTime":"2026-07-27 17:31","pubTimestamp":1785144708,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nFWN43R0DM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","HK0000165453.HKD","LU1328277881.USD","LU1951186391.HKD","LU0501845795.SGD","IE0008368742.USD","LU1960683339.HKD","SG9999004220.SGD","BK1521","LU1813983027.USD","KURE","LU1152091754.HKD","LU2039709279.SGD","IE00BZ08YT58.USD","LU1008478684.HKD","IE0008369823.USD","LU0072913022.USD","IE00B5MMRT66.SGD","LU1152091168.USD","BK1191","LU1226287529.USD","LU0314109678.HKD","IE00BZ08YR35.GBP","LU1993786604.SGD","LU0140636845.USD","IE00B031HY20.USD","IE00B543WZ88.USD","LU0326950275.SGD","LU0067412154.USD","LU1226287875.USD","LU1226288253.USD","LU0315179316.USD","01093","IE00BZ08YS42.EUR","LU1226287792.SGD","LU1226288170.HKD","LU0880133367.SGD","LU1807302812.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654150770","title":"CSPC Pharmaceutical - Expected Result Due to Significant Increase in Licence Fee Income, Others in Hy","url":"https://stock-news.laohu8.com/highlight/detail?id=2654150770","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654150770?lang=en_us&edition=fundamental","pubTime":"2026-07-27 17:31","pubTimestamp":1785144708,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nFWN43R0DM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1521","LU2039709279.SGD","LU1813983027.USD","LU1226288170.HKD","KURE","LU1328277881.USD","LU1993786604.SGD","LU0880133367.SGD","IE00B031HY20.USD","LU0314109678.HKD","BK1515","LU1807302812.USD","IE00B5MMRT66.SGD","IE0008369823.USD","LU0326950275.SGD","LU1960683339.HKD","LU1226287875.USD","LU1226287529.USD","IE00BZ08YS42.EUR","LU1226287792.SGD","LU1951186391.HKD","LU1226288253.USD","LU0140636845.USD","SG9999004220.SGD","IE00B543WZ88.USD","01093","LU1152091168.USD","IE0008368742.USD","LU0501845795.SGD","LU1152091754.HKD","HK0000165453.HKD","LU0067412154.USD","LU0072913022.USD","LU0315179316.USD","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","BK1191","LU1008478684.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654001872","title":"CSPC Pharmaceutical Group Stock Falls 2.9% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2654001872","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654001872?lang=en_us&edition=fundamental","pubTime":"2026-07-27 16:31","pubTimestamp":1785141060,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. shed 2.9% to 8.30 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.0% to 25207.18.CSPC Pharmaceutical Group Ltd. closed 29% short of its 52-week high of HK$11.63, which the company achieved Sept. 9.The stock underperformed when compared to some of its competitors, as Sino Biopharmaceutical Ltd. fell 1.2%, SSY Group Ltd. fell 0.4%, and United Laboratories International Holdings Ltd. remained unchanged.Trading volume totaled 78.3 million shares, compared to the 50-day average of 107.0 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 27, 2026 04:31 ET Copyright  2026 Dow Jones & Company, Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0140636845.USD","LU0880133367.SGD","LU0326950275.SGD","LU0067412154.USD","LU1226287529.USD","BK1515","LU1813983027.USD","LU0315179316.USD","LU1226288253.USD","LU1226287792.SGD","LU1008478684.HKD","LU1951186391.HKD","IE00BZ08YT58.USD","IE0008368742.USD","LU1226287875.USD","IE00B5MMRT66.SGD","IE00BZ08YS42.EUR","SG9999004220.SGD","KURE","IE00B031HY20.USD","BK1521","LU1807302812.USD","IE00B543WZ88.USD","LU0072913022.USD","LU1328277881.USD","LU2039709279.SGD","LU1152091168.USD","HK0000165453.HKD","IE00BZ08YR35.GBP","LU1993786604.SGD","LU0314109678.HKD","BK1191","IE0008369823.USD","LU0501845795.SGD","LU1152091754.HKD","01093","LU1960683339.HKD","LU1226288170.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654097755","title":"Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$10.31 From HK$12.04, Keeps at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2654097755","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654097755?lang=en_us&edition=fundamental","pubTime":"2026-07-27 15:20","pubTimestamp":1785136834,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group (HKG:1093) has an average rating of overweight and mean price target of HK$11.64, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B031HY20.USD","BK1521","KURE","HK0000165453.HKD","SG9999004220.SGD","LU0314109678.HKD","LU0072913022.USD","LU0140636845.USD","IE00B543WZ88.USD","IE00BZ08YS42.EUR","LU1226288253.USD","LU0880133367.SGD","LU1951186391.HKD","LU1993786604.SGD","IE00B5MMRT66.SGD","LU1960683339.HKD","LU1328277881.USD","LU1226287875.USD","LU0067412154.USD","BK1515","LU0501845795.SGD","IE00BZ08YR35.GBP","IE0008369823.USD","LU0315179316.USD","LU1226288170.HKD","LU1008478684.HKD","BK1191","LU1152091754.HKD","IE00BZ08YT58.USD","LU0326950275.SGD","LU1226287529.USD","LU1807302812.USD","LU1152091168.USD","LU1813983027.USD","LU1226287792.SGD","01093","LU2039709279.SGD","IE0008368742.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654309720","title":"Nomura Adjusts Akeso's Price Target to HK$138.29 From HK$142.50, Keeps at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2654309720","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654309720?lang=en_us&edition=fundamental","pubTime":"2026-07-27 15:18","pubTimestamp":1785136736,"startTime":"0","endTime":"0","summary":"Akeso (HKG:9926) has an average rating of buy and mean price target of HK$170.79, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0540923850.HKD","LU0348735423.USD","LU0417516738.SGD","LU0348827113.USD","LU0348784397.USD","LU1961090484.USD","LU0348783233.USD","LU0348825331.USD","KURE","LU0348767384.USD","LU2399975544.HKD","LU0417516902.SGD","BK1161","LU2476274308.USD","LU2476274720.SGD","BK1574","09926","IE00B543WZ88.USD","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","LU0561508036.HKD","LU0417516571.SGD","LU0348766576.USD","LU2778985437.USD","LU2488822045.USD","LU1794554557.SGD","LU1720050803.USD","LU0634319403.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654097509","title":"Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$51.38 From HK$50.54, Keeps at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2654097509","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654097509?lang=en_us&edition=fundamental","pubTime":"2026-07-27 15:02","pubTimestamp":1785135770,"startTime":"0","endTime":"0","summary":"WuXi Biologics (Cayman) (HKG:2269) has an average rating of overweight and mean price target of HK$48.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1521","LU0856984785.SGD","IE00B0JY6N72.USD","LU0823426308.USD","LU2039709279.SGD","LU0823426480.USD","LU0320764599.SGD","LU1794554557.SGD","KURE","LU0456846285.SGD","LU0417516738.SGD","LU0516422366.SGD","LU1242518931.SGD","LU0043850808.USD","LU0572944931.SGD","LU0348735423.USD","LU0708995583.HKD","LU0181495838.USD","LU0516423174.USD","SG9999002463.SGD","LU0516422952.EUR","LU0326950275.SGD","LU1720050803.USD","LU0417516902.SGD","LU0051755006.USD","LU1242518857.USD","LU0348825331.USD","LU0819121731.USD","BK1141","BK1576","LU0516423091.SGD","LU0140636845.USD","LU0359201612.USD","LU0588546209.SGD","LU0052750758.USD","02269","LU0359202008.SGD","LU0307460666.USD","LU0979878070.USD","LU1688375341.USD","LU0039217434.USD","LU0516422440.USD","BK1589","LU3063872942.SGD","SG9999002562.SGD","LU0327786744.USD","LU1880383366.USD","LU0456827905.SGD","BK1610"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654047803","title":"Chinese biotech overtakes AI as emerging-market growth trade","url":"https://stock-news.laohu8.com/highlight/detail?id=2654047803","media":"Srinivasan Sivabalan / Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654047803?lang=en_us&edition=fundamental","pubTime":"2026-07-27 06:33","pubTimestamp":1785105227,"startTime":"0","endTime":"0","summary":"As the artificial-intelligence rally sputters in emerging markets, investors searching for high-growth alternatives are turning to Chinese biotech.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/healthcare/chinese-biotech-overtakes-ai-emerging-market-growth-trade?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/healthcare/chinese-biotech-overtakes-ai-emerging-market-growth-trade?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["KURE","NVIB","AGIX","QQQW","CHAT","AIPO","ARTY","QTOC","VTHR","XBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654062572","title":"CSPC Pharmaceutical Group (SEHK:1093) Could Be 115% Below Fair Value Following Drug Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2654062572","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654062572?lang=en_us&edition=fundamental","pubTime":"2026-07-27 01:18","pubTimestamp":1785086285,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group (SEHK:1093) has secured marketing approval in China for its once-monthly Paliperidone Palmitate Injection for schizophrenia, a development that broadens its psychiatric and neurological drug portfolio.\nSee our latest analysis for CSPC Pharmaceutical Group.\nThe marketing approval for CSPC Pharmaceutical Group’s Paliperidone Palmitate Injection comes as momentum in the stock has recently strengthened. The 30 day share price return is 28.57%, following earlier 90 day...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1093/cspc-pharmaceutical-group-shares/news/cspc-pharmaceutical-group-sehk1093-could-be-115-below-fair-v","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1093/cspc-pharmaceutical-group-shares/news/cspc-pharmaceutical-group-sehk1093-could-be-115-below-fair-v","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1951186391.HKD","SG9999004220.SGD","LU1993786604.SGD","LU1960683339.HKD","LU0880133367.SGD","VGFPF","PMDE","01093","IE00B543WZ88.USD","RGLO","VOTE","IE0008369823.USD","IE00BZ08YT58.USD","LU0067412154.USD","LU1813983027.USD","LU1226287529.USD","KURE","LU0315179316.USD","BK1521","JOYT","LU0140636845.USD","LU1328277881.USD","FEBU","LU1226287792.SGD","LU1226287875.USD","LU0501845795.SGD","LU1152091168.USD","IE00BZ08YS42.EUR","BK1515","LU2039709279.SGD","LU1807302812.USD","LU1008478684.HKD","GXDW","IE0008368742.USD","BK1191","DECU","LU0072913022.USD","DCF","IE00BZ08YR35.GBP","LU0326950275.SGD","LU1226288170.HKD","IE00B5MMRT66.SGD","LU1152091754.HKD","IE00B031HY20.USD","LU1226288253.USD","HK0000165453.HKD","LU0314109678.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177071062","title":"Obesity Specialty Standardized Weight Management Service System Initiative Launches in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1177071062","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177071062?lang=en_us&edition=fundamental","pubTime":"2026-07-26 22:41","pubTimestamp":1785076876,"startTime":"0","endTime":"0","summary":"On July 26, the \"Obesity Specialty - Standardized Weight Management Service System for Medical Institutions\" project, led by the Endocrine and Metabolic Obesity Diagnosis and Treatment Alliance,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1589","LU2328871848.SGD","LU2097828805.USD","LU2488822045.USD","LU0502904849.HKD","LU2097828474.EUR","LU1969619763.USD","LU2242644610.SGD","HK0000165453.HKD","BK1161","01801","LU2097828714.EUR","LU2097828557.USD","KURE","LU0455707207.USD","LU2097828631.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193396300","title":"AKESO (09926) Grants 3,603,500 Share Options and 1,648,500 Restricted Share Units","url":"https://stock-news.laohu8.com/highlight/detail?id=1193396300","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193396300?lang=en_us&edition=fundamental","pubTime":"2026-07-26 19:58","pubTimestamp":1785067091,"startTime":"0","endTime":"0","summary":"AKESO (09926) has announced that on July 24, 2026, the company granted 3,603,500 share options to 167 grantees under its share option scheme, with an exercise price of HKD 99.5 per option.On the same...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0561508036.HKD","IE00BPRC5H50.USD","BK1574","BK1161","09926","LU1961090484.USD","LU0348784397.USD","IE00B543WZ88.USD","LU2476274308.USD","LU0348766576.USD","LU1720050803.USD","LU0540923850.HKD","LU0348783233.USD","LU1794554557.SGD","LU0417516738.SGD","LU0348735423.USD","LU2778985437.USD","LU0417516902.SGD","IE00B5MMRT66.SGD","KURE","LU0348825331.USD","LU2476274720.SGD","LU2399975544.HKD","LU0348827113.USD","LU0348767384.USD","LU0417516571.SGD","LU0634319403.HKD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654066635","title":"Akeso Grants 3,603,500 Share Options at HK$ 99.5 Exercise Price Under Employee Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2654066635","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654066635?lang=en_us&edition=fundamental","pubTime":"2026-07-26 19:52","pubTimestamp":1785066759,"startTime":"0","endTime":"0","summary":"Akeso grants 3,603,500 share options at HK$ 99.5 exercise price under employee incentive planAkeso granted 3,603,500 share options on July 24, 2026 to 167 directors, executives, and employees.Options ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260726:nNDL2tnMB7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348735423.USD","LU0348783233.USD","LU0417516738.SGD","LU0348825331.USD","LU0348766576.USD","LU0417516902.SGD","LU2778985437.USD","IE00BPRC5H50.USD","LU0561508036.HKD","LU0348784397.USD","LU0417516571.SGD","IE00B5MMRT66.SGD","BK1574","LU0634319403.HKD","LU2399975544.HKD","LU1794554557.SGD","09926","LU1961090484.USD","LU1720050803.USD","LU2476274308.USD","LU2488822045.USD","LU2476274720.SGD","KURE","LU0348827113.USD","LU0348767384.USD","IE00B543WZ88.USD","LU0540923850.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653003567","title":"Akeso (SEHK:9926) Partners With MSK, Is The Discount To Fair Value Justified?","url":"https://stock-news.laohu8.com/highlight/detail?id=2653003567","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653003567?lang=en_us&edition=fundamental","pubTime":"2026-07-24 22:24","pubTimestamp":1784903090,"startTime":"0","endTime":"0","summary":"Akeso (SEHK:9926) has drawn fresh investor attention after partnering with Memorial Sloan Kettering Cancer Center on a Phase II study of cadonilimab based therapy for HER2 negative gastric and gastroesophageal junction adenocarcinoma.\nSee our latest analysis for Akeso.\nAkeso's latest collaboration arrives after a mixed stretch in the stock, with the 7 day share price return up 12.62% and the 1 month share price return up 13.71%, but the year to date share price return down 12.18% and the 1...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-partners-with-msk-is-the-discount-to-fair-val","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-partners-with-msk-is-the-discount-to-fair-val","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0348735423.USD","LU0540923850.HKD","IE00B543WZ88.USD","LU1961090484.USD","BK1574","09926","LU2488822045.USD","IE00B5MMRT66.SGD","LU0348767384.USD","KURE","LU0348825331.USD","LU0417516571.SGD","LU2778985437.USD","LU0348766576.USD","LU0634319403.HKD","IE00BPRC5H50.USD","LU0348784397.USD","LU0561508036.HKD","LU0417516902.SGD","LU2476274720.SGD","LU1794554557.SGD","LU0417516738.SGD","BK1161","LU0348827113.USD","LU0348783233.USD","LU2399975544.HKD","LU1720050803.USD","LU2476274308.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192093154","title":"Hong Kong Stock Market Analysis: ChangXin IPO Pressure Weighs, Agricultural Inflation Risks Boost Related Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1192093154","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192093154?lang=en_us&edition=fundamental","pubTime":"2026-07-24 20:24","pubTimestamp":1784895881,"startTime":"0","endTime":"0","summary":"The market faced significant headwinds as the heavyweight ChangXin Technology is set to list on the Shanghai Stock Exchange's STAR Market on July 27. Today, A-share turnover fell below 2 trillion...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","02218","IE00BZ08YS42.EUR","LU1251922891.USD","LU0593848301.USD","EVS.SI","LU0072913022.USD","LU1861214812.USD","BK1616","603986","LU1044876610.USD","IE0008368742.USD","LU0314109678.HKD","BK1191","LU1211504680.USD","LU0516423091.SGD","LU0880133367.SGD","06809","BK1237","LU0293314216.USD","LU0228367735.SGD","LU0326950275.SGD","LU1226287792.SGD","01093","LU0417516738.SGD","LU0315179316.USD","IE00BVYPNP33.GBP","LU0149534421.HKD","LU1152091168.USD","06160","BK1117","IE0008369823.USD","BK1583","LU1152091754.HKD","LU1226288253.USD","BK1539","KURE","00189","BK1588","LU0588546209.SGD","LU1642822792.SGD","LU1130305938.SGD","IE00B5MMRT66.SGD","BK1594","BK1607","BK1572","BK1522","02589","BK1163","LU0516423174.USD","HK0000165453.HKD","LU1226288170.HKD","SG9999004220.SGD","LU0516422366.SGD","BK1521","LU1861219969.SGD","IE00B031HY20.USD","82388","BK1560","IE00BZ08YR35.GBP","LU2039709279.SGD","LU0955669360.SGD","BK1500","02388","LU1813983027.USD","LU0163747925.USD","BK1170","LU1226287529.USD","BK1526","LU1224444064.USD","LU0320764599.SGD","BK1507","688981","LU1807302812.USD","ONC","688008","LU1044875133.USD","LU1328277881.USD","02356","SG9999014674.SGD","BK1231","LU0607220059.USD","LU0359202008.SGD","LU1719994722.HKD","LU2328871848.SGD","BK1119","LU1960683339.HKD","BK1601","LU0708995583.HKD","605198","80175","LU1226287875.USD","IE00B0JY6N72.USD","BK1614","300433","06613","LU1023057109.AUD","BK1161","LU0307460666.USD","BKEAY","LU1951186391.HKD","IE00BZ08YT58.USD","03143","LU0067412154.USD","BK1553","BK1610","IE00B543WZ88.USD","03986","00175","LU1969619763.USD","LU0955623706.USD","LU1008478684.HKD","00023","BK1129","LU0359201612.USD","09863","BK1511","LU0348735423.USD","LU0140636845.USD","BK1587","LU1328615791.USD","BK1212","BK1589","LU0052750758.USD","01117","BK1233","02513","LU1303224171.USD","LU0414403682.SGD","LU0501845795.SGD","LU1993786604.SGD","688235","LU0359201885.HKD","BHKLY","00981","LU0738912210.USD","LU1770034418.SGD","LU2360107325.USD","IE00BVYPNQ40.USD","IE00BGHQDM52.EUR","LU1044874839.SGD","LU1282651121.HKD","LU0516422440.USD","LU0516422952.EUR","SG9999002828.SGD","GELYY","LU0955648018.USD","LU1282651048.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109736656","title":"CSPC Pharma's Paliperidone Palmitate Injection Receives Market Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1109736656","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109736656?lang=en_us&edition=fundamental","pubTime":"2026-07-24 18:50","pubTimestamp":1784890218,"startTime":"0","endTime":"0","summary":"CSPC Pharma (HKEx: 01093) has announced that its self-developed second-generation long-acting antipsychotic injectable, Paliperidone Palmitate Injection, has received marketing approval from China's...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0880133367.SGD","IE00B5MMRT66.SGD","IE00B031HY20.USD","BK1515","IE00BZ08YT58.USD","LU1152091168.USD","LU1226287875.USD","LU1328277881.USD","KURE","LU0314109678.HKD","LU1226288253.USD","LU1807302812.USD","LU0315179316.USD","LU0326950275.SGD","LU0140636845.USD","LU1226287792.SGD","LU1951186391.HKD","IE00B543WZ88.USD","HK0000165453.HKD","LU1960683339.HKD","IPOS","IE0008368742.USD","LU1226288170.HKD","01093","LU1993786604.SGD","BK1191","IE00BZ08YR35.GBP","LU1008478684.HKD","LU1152091754.HKD","LU0072913022.USD","LU0501845795.SGD","IE0008369823.USD","BK1521","LU0067412154.USD","LU1226287529.USD","IE00BZ08YS42.EUR","SG9999004220.SGD","LU1813983027.USD","LU2039709279.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653086198","title":"CSPC Pharma Wins China Approval for Paliperidone Palmitate Schizophrenia Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2653086198","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653086198?lang=en_us&edition=fundamental","pubTime":"2026-07-24 18:44","pubTimestamp":1784889888,"startTime":"0","endTime":"0","summary":"CSPC Pharma wins China approval for paliperidone palmitate schizophrenia injectionCSPC Pharmaceutical received China NMPA marketing clearance for its paliperidone palmitate long-acting injection to tr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nNDL8GzVZS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0880133367.SGD","LU1993786604.SGD","LU1807302812.USD","LU1328277881.USD","LU1813983027.USD","IE00BZ08YT58.USD","01093","KURE","LU1152091168.USD","LU2039709279.SGD","LU0067412154.USD","IE0008369823.USD","IE0008368742.USD","LU0501845795.SGD","LU1226288253.USD","LU0314109678.HKD","LU0072913022.USD","LU0315179316.USD","IE00BZ08YR35.GBP","LU1226287792.SGD","HK0000165453.HKD","LU1960683339.HKD","LU1951186391.HKD","BK1521","BK1191","IE00B031HY20.USD","LU1226288170.HKD","LU0326950275.SGD","LU0140636845.USD","LU1008478684.HKD","LU1226287529.USD","IE00B5MMRT66.SGD","LU1226287875.USD","BK1515","LU1152091754.HKD","IE00B543WZ88.USD","IE00BZ08YS42.EUR","SG9999004220.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653008618","title":"CSPC Pharmaceutical - Paliperidone Palmitate Injection Receives Marketing Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2653008618","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653008618?lang=en_us&edition=fundamental","pubTime":"2026-07-24 18:44","pubTimestamp":1784889860,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nFWN43Q0P7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B5MMRT66.SGD","LU1328277881.USD","LU0501845795.SGD","LU0315179316.USD","IE00BZ08YT58.USD","LU1813983027.USD","IE00B031HY20.USD","LU1152091754.HKD","BK1521","HK0000165453.HKD","IE00B543WZ88.USD","LU1226287792.SGD","LU0326950275.SGD","LU1226288253.USD","LU1807302812.USD","LU1226287529.USD","IE0008368742.USD","LU2039709279.SGD","IE00BZ08YS42.EUR","IE0008369823.USD","LU1993786604.SGD","LU1226288170.HKD","LU1152091168.USD","SG9999004220.SGD","LU0880133367.SGD","01093","LU1008478684.HKD","LU1951186391.HKD","LU1226287875.USD","BK1515","LU0140636845.USD","LU0072913022.USD","LU1960683339.HKD","BK1191","KURE","LU0067412154.USD","LU0314109678.HKD","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653707153","title":"Wuxi Biologics Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2653707153","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653707153?lang=en_us&edition=fundamental","pubTime":"2026-07-24 16:32","pubTimestamp":1784881975,"startTime":"0","endTime":"0","summary":"WuXi Biologics schedules board meeting to review interim resultsWuXi Biologics schedules a board meeting in Hong Kong on Aug. 25, 2026 to review interim results for the six months ended June 30, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nNDLb2v35Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0051755006.USD","LU1880383366.USD","LU0039217434.USD","BK1589","BK1521","LU0140636845.USD","LU0320764599.SGD","LU0359202008.SGD","LU0417516902.SGD","LU0456827905.SGD","LU0516422440.USD","LU0823426480.USD","LU2039709279.SGD","LU0326950275.SGD","LU0588546209.SGD","LU1688375341.USD","SG9999002463.SGD","LU0327786744.USD","LU0516422952.EUR","02269","BK1141","LU0359201612.USD","LU0348825331.USD","LU0417516738.SGD","LU1794554557.SGD","LU0516423091.SGD","IE00B0JY6N72.USD","LU0819121731.USD","LU0043850808.USD","LU0708995583.HKD","LU0823426308.USD","LU1242518931.SGD","LU1720050803.USD","SG9999002562.SGD","BK1576","LU0307460666.USD","LU0516423174.USD","LU0516422366.SGD","LU0348735423.USD","LU0856984785.SGD","LU3063872942.SGD","LU0979878070.USD","BK1610","LU0181495838.USD","LU1242518857.USD","LU0052750758.USD","LU0572944931.SGD","KURE","LU0456846285.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653071767","title":"CSPC Pharmaceutical Group Stock Rises 2.2% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2653071767","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653071767?lang=en_us&edition=fundamental","pubTime":"2026-07-24 16:32","pubTimestamp":1784881920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. advanced 2.2% to 8.55 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.0% to 24963.23.The stock's rise snapped a three-day losing streak.CSPC Pharmaceutical Group Ltd. closed 26% short of its 52-week high of HK$11.63, which the company reached Sept. 9.The stock outperformed some of its competitors, as Sino Biopharmaceutical Ltd. fell 0.8%, SSY Group Ltd. remained unchanged, and United Laboratories International Holdings Ltd. fell 0.4%.Trading volume totaled 136.3 million shares, compared to the 50-day average of 106.8 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 24, 2026 04:32 ET Copyright  2026 Dow Jones & Company, Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0140636845.USD","LU0880133367.SGD","LU0326950275.SGD","LU0067412154.USD","LU1226287529.USD","BK1515","LU1813983027.USD","LU0315179316.USD","LU1226288253.USD","LU1226287792.SGD","LU1008478684.HKD","LU1951186391.HKD","IE00BZ08YT58.USD","IE0008368742.USD","LU1226287875.USD","IE00B5MMRT66.SGD","IE00BZ08YS42.EUR","SG9999004220.SGD","KURE","IE00B031HY20.USD","BK1521","LU1807302812.USD","IE00B543WZ88.USD","LU0072913022.USD","LU1328277881.USD","LU2039709279.SGD","LU1152091168.USD","HK0000165453.HKD","IE00BZ08YR35.GBP","LU1993786604.SGD","LU0314109678.HKD","BK1191","IE0008369823.USD","LU0501845795.SGD","LU1152091754.HKD","01093","LU1960683339.HKD","LU1226288170.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145338164","title":"BeiGene Invests Additional $300 Million in US Expansion, Stock Hits 3-Month High; Hong Kong Stock Connect Innovative Drugs Show Local Strength, 520880 Rises for Third Consecutive Day Against Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1145338164","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145338164?lang=en_us&edition=fundamental","pubTime":"2026-07-24 10:12","pubTimestamp":1784859132,"startTime":"0","endTime":"0","summary":"On July 24th, Hong Kong stocks fell again, with the Hang Seng Index dropping over 1%. Pharmaceutical stocks bucked the trend and moved higher, with innovative drug leaders pushing upward once more....","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0588546209.SGD","BK1588","BK1500","159992","BK4526","FLHK","ONC","688235","LU1303224171.USD","LU1770034418.SGD","LU1251922891.USD","LNGR","BK1583","BK4588","520880","LU1719994722.HKD","06160","BK4139","LU2328871848.SGD","LU0307460666.USD","BK0239","06978","IBBQ","BK1161","BK4585","MEDX","LU1969619763.USD","KURE","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}